ULB
" Within the INOCS team (ULB and INRIA Lille), we currently build expertise on methods to develop optimal design of group testing experiments. "
Contact: Bernard Fortz bernard.fortz@ulb.ac.be
ULB
" Production de visières à destination du personnel soignant en collaboration avec le Fablab ULB et le Your Lab. Plans en open source. - Mise en place d'une carte interactive des entreprises oeuvrant dans la lutte contre le covid-19 en collaboration avec le Fablab de Mons et le Fablab Wapi. Objectif de la carte : la mise en valeur des opérateurs économiques. - prototypage de pièces en 3D à la demande des hôpitaux - Prototypage de parois séparatrices en plexi (plan en open source) "
Contact: Fab-C Fablab Charleroi Métropole delphine.dauby@ulb.ac.be fablab-charleroi.be faceshield-fabc.be
Aesculape CRO Belgium BV
" Treatment of COVID 19 complications with antibodies "
Funding: partly public partly private
Contact : jpdeslypere@aesculape.com 0492 735931
ULiège + Mesylab SRL
" How to securely return to normalcy at work? All countries consider to lift the lockdown, but few have executed it. There are no "best practices". Questions abound: What are the risks? What are the most effective measures? Will communities follow? What are the consequences for our individual lives? Who decides how to proceed? AIMS OF THE PROJECT GIGA aims at defining the best possible approach to opening up again by involving its members. Your opinion matters. GIGA has sought assistance in conducting this real time experiment from political scientists, philosophers, lawyers and medical doctors. "
Contact: This project is supported by the GIGA office and is coordinated by the ad hoc Advisory Committee made up of expert political scientists in participation (Dr. F. Thoreau, Dr. C. Parotte, Dr. P. Delvenne, Dr. C. Fallon), a political and ethicist philosopher (Dr. F. Caeymaex) and doctors (Dr. Y. Beguin, Dr. G. Darcis).
UCLouvain
" www.covidata.be We gather data about the Coronavirus in Belgium, and attempt to extract meaningful information from it. We use open and/or public data to enable these analyses. "
Funding: No funding
Publication References: Work in progress
Contact: pierre.schaus@uclouvain.be
USL-B
" The pharmaceutical industry is confronted with many different issues at the levels of logistics and supply chain management. Traceability is a paramount in the pharmaceutical sector. It is not only essential to ensure the quality of the product, but also, it is required to trace possible adverse reactions back to a given lot of drug product, its manufacturing and control. Traceability needs to be addressed at three stages. First, the source (supplier) and origin (e.g. chemical, microbiological, animal, human…) of raw and starting materials must be identified. These materials must be tested and found compliant with compendial requirements. Second, traceability must be ensured in-house, throughout the all manufacturing process, from starting materials to the drug product, through the drug substance and all intermediates. Third, traceability should be ensured downstream, from lot release by the company to patient's administration. Traceability within the industry (stage 2) is...
